Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Inuvo reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Inuvo announced earnings per share of $-0.0200 on revenue of $17.07M. Analysts polled by Investing.com EPS of $-0.0150 on revenue of $22.47M.
Inuvo 's are down 20% and is trading at $0.4330 , still down 39.85% from its 52 week high of $0.72 set on Monday, November 15, 2021.
Inuvo follows other major Information Technology sector earnings this month
Inuvo's report follows an earnings beat by Apple on Thursday, October 27, 2022, who reported EPS of $1.29 on revenue of $90.1B, EPS of $1.26 on revenue of $88.76B.
Microsoft had beat expectations on Tuesday, October 25, 2022 with first quarter EPS of $2.35 on revenue of $50.1B, for EPS of $2.32 on revenue of $49.86B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar